Antiviral activities of Polygonum perfoliatum L. extract and related phenolic acid constituents against hepatitis B virus

J Med Virol. 2022 Dec;94(12):5987-5999. doi: 10.1002/jmv.28087. Epub 2022 Sep 1.

Abstract

Chronic hepatitis B virus (HBV) infection is an important public health problem. Polygonum perfoliatum L. is a traditional medicinal herb and has been reported to have pharmacological activities such as anti-inflammatory, antibacterial, and antiviral. In this study, the antiviral activities and mechanisms of Polygonum perfoliatum L. extract against HBV and the effective components were investigated. The results showed that the total extract of Polygonum perfoliatum L. reduced the levels of HBV e antigen (HBeAg) secretion and the viral covalently closed circular DNA (CCC DNA) formation, but had little or no negative effects on viral capsid assembly and pregenomic RNA packaging. Further fractionation showed that the water extract (WE) fraction exerted comparable anti-HBV activities with the total extract, especially in inhibiting the CCC DNA formation and HBeAg production, indicating that the effective antiviral components are mainly distributed in this fraction. Further study showed that the phenolic acids constituents, protocatechuic acid, and gallic acid, but not ethyl caffeate, which is reported enriched in the WE fraction, showed strong anti-HBV activities in inhibiting viral core DNA synthesis, CCC DNA formation, and HBeAg production. These results suggested that the Polygonum perfoliatum L. total extract and the related phenolic acids like protocatechuic acid and gallic acid could inhibit HBV replication and also indicated the potential utility of Polygonum perfoliatum L. and related constituents as sources of novel antivirals against HBV.

Keywords: CCC DNA formation; HBeAg production; Polygonum perfoliatum L.; hepatitis B virus; phenolic acids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • DNA, Circular
  • DNA, Viral
  • Gallic Acid / pharmacology
  • Gallic Acid / therapeutic use
  • Hepatitis B e Antigens
  • Hepatitis B virus / genetics
  • Hepatitis B*
  • Hepatitis B, Chronic*
  • Humans
  • Hydroxybenzoates
  • Polygonum* / genetics
  • RNA / pharmacology
  • RNA / therapeutic use
  • Virus Replication
  • Water / pharmacology

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents
  • DNA, Circular
  • DNA, Viral
  • Hepatitis B e Antigens
  • Hydroxybenzoates
  • Water
  • protocatechuic acid
  • RNA
  • Gallic Acid
  • phenolic acid